Paper36747244
Safety of metformin continuation in diabetic patients undergoing invasive coronary angiography: the NO-STOP single arm trial.
Chiarito M and 16 others. Cardiovasc Diabetol, 2023. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Safety of metformin continuation in diabetic patients undergoing invasive coronary angiography: the NO-STOP single arm trial. Papers, record 36747244. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36747244
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acidosis, Lactic | Major topic |
| Acute Kidney Injury | Major topic |
| Diabetes Mellitus | Major topic |
| Metformin | Major topic |
| Humans | |
| Coronary Angiography | |
| Hypoglycemic Agents | |
| Lactates | |
| Prospective Studies |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT04766008 | Metformin in Diabetic Patients Undergoing Coronary Angiography | Derived from the trial | Yes |
Source ClinicalTrials.gov
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30667361 | 2018 ESC/EACTS Guidelines on myocardial revascularization. | EuroIntervention | 2019 | https://conductscience.org/library/papers/30667361 | PubMed |
| 2 | 22965137 | Periprocedural management of the patient with diabetes mellitus undergoing coronary angiography: current practice. | Arch Intern Med | 2012 | https://conductscience.org/library/papers/22965137 | PubMed |
| 3 | 18945920 | Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. | Diabetes Care | 2009 | https://conductscience.org/library/papers/18945920 | PubMed |
| 4 | 10359389 | Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. | JAMA | 1999 | https://conductscience.org/library/papers/10359389 | PubMed |
| 5 | 30165617 | Fourth universal definition of myocardial infarction (2018). | Eur Heart J | 2019 | https://conductscience.org/library/papers/30165617 | PubMed |
| 6 | 25317875 | The target of metformin in type 2 diabetes. | N Engl J Med | 2014 | https://conductscience.org/library/papers/25317875 | PubMed |
| 7 | 20338463 | Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. | Am J Kidney Dis | 2010 | https://conductscience.org/library/papers/20338463 | PubMed |
| 8 | 34895951 | 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. | J Am Coll Cardiol | 2022 | https://conductscience.org/library/papers/34895951 | PubMed |
| 9 | 27656713 | Effect of Metformin on Renal Function After Primary Percutaneous Coronary Intervention in Patients Without Diabetes Presenting with ST-elevation Myocardial Infarction: Data from the GIPS-III Trial. | Cardiovasc Drugs Ther | 2015 | https://conductscience.org/library/papers/27656713 | PubMed |
| 10 | 19414839 | A new equation to estimate glomerular filtration rate. | Ann Intern Med | 2009 | https://conductscience.org/library/papers/19414839 | PubMed |
| 11 | 34187171 | Evidence-Based Practices in the Cardiac Catheterization Laboratory: A Scientific Statement From the American Heart Association. | Circulation | 2021 | https://conductscience.org/library/papers/34187171 | PubMed |
| 12 | 21851878 | Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. | J Am Coll Cardiol | 2011 | https://conductscience.org/library/papers/21851878 | PubMed |
| 13 | 26773926 | Metformin-associated lactic acidosis: Current perspectives on causes and risk. | Metabolism | 2016 | https://conductscience.org/library/papers/26773926 | PubMed |
| 14 | 24630791 | Periprocedural glycemic control in patients with diabetes mellitus undergoing coronary angiography with possible percutaneous coronary intervention. | Am J Cardiol | 2014 | https://conductscience.org/library/papers/24630791 | PubMed |
| 15 | 20032157 | Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin. | Radiology | 2010 | https://conductscience.org/library/papers/20032157 | PubMed |
| 16 | 15464318 | A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. | J Am Coll Cardiol | 2004 | https://conductscience.org/library/papers/15464318 | PubMed |
| 17 | 32316910 | Effect of continuous use of metformin on kidney function in diabetes patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. | BMC Cardiovasc Disord | 2020 | https://conductscience.org/library/papers/32316910 | PubMed |
| 18 | 35058000 | Randomized Comparison of Metformin Continuation Versus Interruption Following Coronary Angiography/Angioplasty: Contemporary Risk for Lactic Acidosis. | JACC Cardiovasc Interv | 2022 | https://conductscience.org/library/papers/35058000 | PubMed |
| 19 | 27060269 | One-year clinical outcome of amphilimus polymer-free drug-eluting stent in diabetes mellitus patients: Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTre rEgistry). | Int J Cardiol | 2016 | https://conductscience.org/library/papers/27060269 | PubMed |
| 20 | 29417249 | Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients : Recommendations for updated ESUR Contrast Medium Safety Committee guidelines. | Eur Radiol | 2018 | https://conductscience.org/library/papers/29417249 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41213823 | Left main percutaneous or surgical revascularisation and subsequent risk of transient and persistent renal dysfunction. | Open Heart | 2025 | https://conductscience.org/library/papers/41213823 | PubMed |
| 39786492 | Beneficial effects of metformin treatment in hyperglycaemic patients affected by ischaemia with no obstructive coronary artery. | Cardiovasc Res | 2025 | https://conductscience.org/library/papers/39786492 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AP2B1 | 163 | PubTator's text mining | https://conductscience.org/library/genes/163 | NCBI Gene |
| REN | 5972 | PubTator's text mining | https://conductscience.org/library/genes/5972 | NCBI Gene |
| SLC5A2 | 6524 | PubTator's text mining | https://conductscience.org/library/genes/6524 | NCBI Gene |
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| METFORMIN | CHEMBL1431 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL1431 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36747244
GET https://conductscience.org/api/papers/v1/36747244/references?page=2